Impact of Graves’ hyperthyroidism treatment on lipid profiles and cholesterol dynamics: a prospective observational study
Open Access
- 1 August 2025
- journal article
- Published by SAGE Publications in Therapeutic Advances in Endocrinology and Metabolism
- Vol. 16
Abstract
Background: The impact of Graves’ hyperthyroidism treatment on lipid metabolism remains unclear. This prospective observational study aimed to clarify the changes in lipid profiles and associated metabolic pathways, including cholesterol synthesis, absorption, and low-density lipoprotein (LDL) receptor regulation, following treatment. Methods: Seventeen patients newly diagnosed with Graves’ hyperthyroidism were enrolled and followed for 6 months after achieving euthyroid status. Serum lipids (total cholesterol, LDL-cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides), apolipoproteins, non-cholesterol sterols (markers of cholesterol synthesis and absorption), proprotein convertase subtilisin/kexin type 9 (PCSK9), and lipoprotein lipase (LPL) levels were measured at baseline, at euthyroid status (Eu-0M), and 6 months after euthyroid status (Eu-6M). Results: After treatment, serum total cholesterol, LDL-C, and HDL-C levels increased rapidly compared to baseline, while triglyceride levels showed a delayed but significant increase at Eu-6M. Levels of apolipoprotein (apo) AI, AII, B, and CIII increased significantly after treatment, whereas apo B-48 increased only at Eu-6M, and apo CII and apo E remained unchanged. Markers of cholesterol synthesis (lathosterol) and absorption (sitosterol, campesterol, and cholestanol) increased significantly after treatment, indicating enhanced cholesterol metabolism. Circulating PCSK9 levels increased significantly and remained elevated, while LPL levels did not change significantly. Conclusion: Treatment of Graves’ hyperthyroidism rapidly increases cholesterol levels through enhanced cholesterol synthesis and absorption, possibly mediated by increased circulating PCSK9.Keywords
Funding Information
- Diversity Promotion Center in Nippon Medical School
This publication has 34 references indexed in Scilit:
- Thyroid Hormone Regulates Hepatic Triglyceride Mobilization and Apolipoprotein B Messenger Ribonucleic Acid Editing in a Murine Model of Congenital HypothyroidismEndocrinology, 2003
- Thyroid Disease and LipidsThyroid®, 2002
- Effect of Thyroid Dysfunction on High-Density Lipoprotein Subfraction Metabolism: Roles of Hepatic Lipase and Cholesteryl Ester Transfer Protein1The Journal of Clinical Endocrinology & Metabolism, 1998
- SERUM PLANT STEROLS AND CHOLESTEROL PRECURSORS REFLECT CHOLESTEROL ABSORPTION AND SYNTHESIS IN VOLUNTEERS OF A RANDOMLY SELECTED MALE POPULATIONAmerican Journal of Epidemiology, 1990
- Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged menMetabolism, 1989
- Thyroid hormone modulates the introduction of a stop codon in rat liver apolipoprotein B messenger RNA.Journal of Biological Chemistry, 1988
- Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans.Journal of Lipid Research, 1988
- Hyperthyroidism Influences the Distribution and Apolipoprotein A Composition of the High Density Lipoproteins in ManThe Journal of Clinical Endocrinology & Metabolism, 1985
- Serum Lipids and Apolipoproteins A-I, A-II, and B in Hyperthyroidism before and after TreatmentThe Journal of Clinical Endocrinology & Metabolism, 1982
- Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative UltracentrifugeClinical Chemistry, 1972